348 related articles for article (PubMed ID: 16497179)
1. Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine.
Nylander O; Pihl L
Acta Physiol (Oxf); 2006 Jan; 186(1):45-58. PubMed ID: 16497179
[TBL] [Abstract][Full Text] [Related]
2. Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum.
Nylander O; Sjöblom M
Acta Physiol (Oxf); 2007 Apr; 189(4):325-35. PubMed ID: 17367402
[TBL] [Abstract][Full Text] [Related]
3. Hypotonicity-induced increases in duodenal mucosal permeability facilitates adjustment of luminal osmolality.
Nylander O; Pihl L; Perry M
Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G360-70. PubMed ID: 12686510
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the effect of luminal hypotonicity on mucosal permeability in rat upper gastrointestinal tract.
Pihl L; Wilander E; Nylander O
Acta Physiol (Oxf); 2008 May; 193(1):67-78. PubMed ID: 18005215
[TBL] [Abstract][Full Text] [Related]
5. Products of cyclooxygenase-2 depress duodenal function in rats subjected to abdominal surgery.
Pihl L; Nylander O
Acta Physiol (Oxf); 2006 Apr; 186(4):279-90. PubMed ID: 16634783
[TBL] [Abstract][Full Text] [Related]
6. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
[TBL] [Abstract][Full Text] [Related]
7. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
de Ridder WJ; Schuurkes JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum.
Tuladhar BR; Kaisar M; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1174-8. PubMed ID: 9401783
[TBL] [Abstract][Full Text] [Related]
9. Serotonin increases protective duodenal bicarbonate secretion via enteric ganglia and a 5-HT4-dependent pathway.
Säfsten B; Sjöblom M; Flemström G
Scand J Gastroenterol; 2006 Nov; 41(11):1279-89. PubMed ID: 17060121
[TBL] [Abstract][Full Text] [Related]
10. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying.
Raybould HE; Glatzle J; Robin C; Meyer JH; Phan T; Wong H; Sternini C
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G367-72. PubMed ID: 12409280
[TBL] [Abstract][Full Text] [Related]
11. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis of components of the change in transmural potential difference evoked by distension of rat proximal small intestine in vivo.
Larsson MH; Sapnara M; Thomas EA; Bornstein JC; Lindström E; Svensson DJ; Sjövall H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G165-73. PubMed ID: 17975133
[TBL] [Abstract][Full Text] [Related]
13. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.
Akiba Y; Maruta K; Narimatsu K; Said H; Kaji I; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G117-G128. PubMed ID: 28526687
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Castejon AM; Paez X; Hernandez L; Cubeddu LX
J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
[TBL] [Abstract][Full Text] [Related]
15. 5-HT induces cAMP production in crypt colonocytes at a 5-HT4 receptor.
Albuquerque FC; Smith EH; Kellum JM
J Surg Res; 1998 Jul; 77(2):137-40. PubMed ID: 9733600
[TBL] [Abstract][Full Text] [Related]
16. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
[TBL] [Abstract][Full Text] [Related]
17. A nonneuronal 5-hydroxytryptamine receptor 3 induces chloride secretion in the rat distal colonic mucosa.
Day J; King B; Haque SM; Kellum JM
Am J Surg; 2005 Nov; 190(5):736-8. PubMed ID: 16226950
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide increases 5-hydroxytryptamine release from the isolated ileum of the rat.
Minami M; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR; Andrews PL
Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):13-24. PubMed ID: 9507564
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat.
Turvill JL; Connor P; Farthing MJ
Br J Pharmacol; 2000 Jul; 130(5):1031-6. PubMed ID: 10882387
[TBL] [Abstract][Full Text] [Related]
20. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
